IonQ’s Stock Loses 13% in a Week Even as Revenue Jumps 755% and Analysts See 76% Upside

IonQ teams up with Jane Goodall Institute on quantum primate research, but stock slides 13% in a week as losses mount despite record Q1 revenue and a 755% year-over-year jump.

IonQ unveiled an unusual research partnership this week, teaming up with the Jane Goodall Institute USA and FormationQ on a two-year project that applies quantum computing to primate behavior. The program, dubbed “Ecology of War and Peace,” will use IonQ’s ion-trap quantum computers to simulate ecological influences on cooperation and conflict among primates, drawing on six decades of field data from Gombe. The announcement, timed to World Chimpanzee Day on July 14, highlights the expanding reach of IonQ’s technology beyond traditional industrial customers. Yet for shareholders, the news has done little to stem a deepening selloff that has erased roughly 13% of the stock’s value in the past seven trading days alone.

IonQ shares closed at €34.35 on Tuesday, bringing the weekly decline to 12.97%. Over the past month the stock has slumped 34.99%, and since the start of the year it has shed 13.91%. The slide comes on the heels of a nine-day losing streak that ended with a brief bounce on falling US inflation data — a recovery that lasted less than 24 hours. Wednesday’s trading saw the stock fall another 3.32% to €33.21, putting the 52-week low of €22.60 from March 30 back within striking distance. At the current price, IonQ trades 53.01% below its 52-week high of €73.10 reached on October 13, 2025.

Technical indicators register a deeply oversold condition. The 14-day relative strength index stands at 30.0, just above the threshold often considered oversold, while the 50-day moving average of €48.09 sits 28.57% above the current price. The 200-day moving average of €41.77 is 17.76% higher. Market capitalisation has fallen to approximately €13.97 billion, and the annualised 30-day volatility has climbed to 84.10% — a level that reflects the intense nervousness gripping the stock.

The fundamental picture, however, tells a starkly different story. In the first quarter of 2026, IonQ reported revenue of $64.67 million, crushing analyst estimates of $49.79 million and representing a staggering 755% year-over-year increase. The backlog swelled more than 550% to $470 million, with commercial clients now accounting for roughly 60% of total revenue. Management raised full-year guidance accordingly, projecting sales between $260 million and $270 million, up from a previous range of $225 million to $245 million.

But profitability remains elusive, and the losses are growing faster than revenue. The operating loss in Q1 hit $271.5 million, and adjusted EBITDA came in at minus $96.8 million. For all of 2026, IonQ expects an adjusted EBITDA loss of $310 million to $330 million, nearly double the $186.75 million loss recorded in 2025. That widening red ink, combined with concerns about cash burn and potential dilution, has given ammunition to short sellers. A recent report from a bearish firm questioned the company’s growth prospects, specifically flagging risks tied to Pentagon-related contract financing and arguing that IonQ’s valuation had detached from its operational trajectory.

Geopolitical headwinds have exacerbated the selling. President Trump’s announcement of a renewed blockade in the Strait of Hormuz — followed by fresh missile strikes — has soured risk appetite across speculative tech names. Quantum-computing stocks, which had rallied on hopes of transformative government spending, have been particularly hard hit.

Yet analysts remain broadly bullish. TipRanks included IonQ on a list of preferred growth stocks alongside Sandisk and Constellation Energy on July 14, noting average price targets of $69.31 — implying 76.41% upside from current levels. The research firm projects a five-year revenue growth rate of 128.22%, and an AI-driven model forecasts 334.58% revenue expansion versus a tech-sector average of just 8.5%. The bullish case rests on sustained demand from government, defence, and commercial segments, as well as the sheer scale of IonQ’s revenue acceleration.

The next major catalyst arrives on August 5, when IonQ reports second-quarter results. Analysts are looking for revenue of roughly $66.5 million. Until then, the stock remains caught between a hammered technical picture — with an RSI in oversold territory — and a growth narrative that, if validated, could draw buyers back in. The partnership with the Jane Goodall Institute, meanwhile, serves as a reminder that IonQ’s quantum technology is finding use cases far outside the data centre, even as its share price struggles to find a floor.